171 related articles for article (PubMed ID: 25073898)
1. Breast carcinoma with choriocarcinomatous features: a case report and review of the literature.
Zhu Y; Liu M; Li J; Jing F; Linghu R; Guo X; Jiao S; Yang J
World J Surg Oncol; 2014 Jul; 12():239. PubMed ID: 25073898
[TBL] [Abstract][Full Text] [Related]
2. Fine needle aspiration cytology of mammary carcinoma with choriocarcinomatous features: a report of 2 cases.
Akbulut M; Zekioglu O; Ozdemir N; Kapkac M
Acta Cytol; 2008; 52(1):99-104. PubMed ID: 18323284
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the breast with choriocarcinomatous features.
Mohammadi A; Rosa M
Arch Pathol Lab Med; 2011 Sep; 135(9):1097-100. PubMed ID: 21877993
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer with choriocarcinomatous features: A case report with cytopathologic details.
Murata T; Ihara S; Nakayama T; Nakagawa SI; Higashiguchi T; Imai T; Nakano H; Shiraishi T; Kuroda M; Moriya T
Pathol Int; 1999 Sep; 49(9):816-9. PubMed ID: 10504554
[TBL] [Abstract][Full Text] [Related]
5. Case report: Metastatic metaplastic breast cancer with choriocarinomatous features: Targeting the choriocarcinoma component for cure.
Mehta KK; Nouvini R; Liu J; Wang Y; Stopeck A
Front Oncol; 2022; 12():1061679. PubMed ID: 36686740
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
7. A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer.
Jinno H; Sakata M; Hayashida T; Takahashi M; Mukai M; Ikeda T; Kitagawa Y
Ann Oncol; 2010 Jun; 21(6):1262-1266. PubMed ID: 19854722
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer with choriocarcinomatous and neuroendocrine features.
Giannotti Filho O; Miiji LN; Vainchenker M; Gordan AN
Sao Paulo Med J; 2001 Jul; 119(4):154-5. PubMed ID: 11500791
[TBL] [Abstract][Full Text] [Related]
9. Treatment for anthracycline-pretreated metastatic breast cancer.
O'Shaughnessy J; Twelves C; Aapro M
Oncologist; 2002; 7 Suppl 6():4-12. PubMed ID: 12454314
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of docetaxel combined capecitabine on metastatic breast cancer].
Wang XX; Zhou ZM; Yuan ZY; Zhang DS; Shi YX; Jiang WQ
Ai Zheng; 2007 Apr; 26(4):407-10. PubMed ID: 17430662
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil– epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy.
Ohno S; Chow LW; Sato N; Masuda N; Sasano H; Takahashi F; Bando H; Iwata H; Morimoto T; Kamigaki S; Nakayama T; Nakamura S; Kuroi K; Aogi K; Kashiwaba M; Yamashita H; Hisamatsu K; Ito Y; Yamamoto Y; Ueno T; Fakhrejahani E; Yoshida N; Toi M
Breast Cancer Res Treat; 2013 Nov; 142(1):69-80. PubMed ID: 24122389
[TBL] [Abstract][Full Text] [Related]
12. Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
Steger GG; Greil R; Lang A; Rudas M; Fitzal F; Mlineritsch B; Hartmann BL; Bartsch R; Melbinger E; Hubalek M; Stoeger H; Dubsky P; Ressler S; Petzer AL; Singer CF; Muss C; Jakesz R; Gampenrieder SP; Zielinski CC; Fesl C; Gnant M;
Ann Oncol; 2014 Feb; 25(2):366-71. PubMed ID: 24347519
[TBL] [Abstract][Full Text] [Related]
13. [Clinical paired study of comparing docetaxel plus capecitabine versus docetaxel plus epirubicin as first-line treatment in women with HER-2 negative advanced breast cancer].
Yang B; Yang JL; Shi WW; Liu H; Zhu YY; Fang P; Ji TF
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1397-400. PubMed ID: 24025504
[TBL] [Abstract][Full Text] [Related]
14. [An effective case of liver metastasis of breast cancer treated with capecitabine + docetaxel combination therapy using vitamin B6].
Umeda T; Abe H; Cho H; Shimizu T; Mori T; Kubota Y; Kawai Y; Tanaka M; Kurumi Y; Tani T
Gan To Kagaku Ryoho; 2010 Apr; 37(4):687-9. PubMed ID: 20414027
[TBL] [Abstract][Full Text] [Related]
15. Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro).
von Minckwitz G; Rezai M; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Blohmer JU; Costa SD; Jackisch C; Paepke S; Schneeweiss A; Kümmel S; Denkert C; Mehta K; Loibl S; Untch M
Ann Oncol; 2014 Jan; 25(1):81-9. PubMed ID: 24273046
[TBL] [Abstract][Full Text] [Related]
16. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer.
Nieto Y; Aramendía JM; Espinós J; De la Cruz S; Fernández-Hidalgo O; Santisteban M; Arbea L; Aristu J; Martínez-Monge R; Moreno M; Pina L; Sola J; Zornoza G; Regueira FM
Cancer Chemother Pharmacol; 2010 Feb; 65(3):457-65. PubMed ID: 19526361
[TBL] [Abstract][Full Text] [Related]
17. Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.
Gómez-Martin C; Sánchez A; Irigoyen A; Llorente B; Pérez B; Serrano R; Safont MJ; Falcó E; Lacasta A; Reboredo M; Aparicio J; Dueñas R; Muñoz ML; Regueiro P; Sanchez-Viñes E; López RL
Clin Transl Oncol; 2012 Sep; 14(9):689-97. PubMed ID: 22855151
[TBL] [Abstract][Full Text] [Related]
18. [Randomized clinical case-control trial for the comparison of docetaxel plus thiotepa versus docetaxel plus capecitabine in patients with metastatic breast cancer].
Yu J; DI Lj; Song Gh; Che L; Jiang Hf; Zhu Yl; Liang X; Jia J; Zhang J; Yang Hb; Wang Xl; Zhou Xn; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):151-6. PubMed ID: 21321641
[TBL] [Abstract][Full Text] [Related]
19. Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer.
Venturini M; Del Mastro L; Garrone O; Angiolini C; Merlano M; Bergaglio M; Tolino G; Lambiase A; Baldini A; Canavese G; Rosso R
Ann Oncol; 2002 Apr; 13(4):546-52. PubMed ID: 12056704
[TBL] [Abstract][Full Text] [Related]
20. A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer.
Bayo J; Lomas M; Salvador J; Moreno A; Ruiz M; Rodríguez A; Fuentes J; Fernández-Freire A; Bernabé R; Fernández A
Clin Transl Oncol; 2008 Dec; 10(12):817-25. PubMed ID: 19068453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
